Ongoing research at Michigan Medicine seeks to understand why certain people develop Antiphospholipid syndrome (APS), to find new and better ways to treat the disease, and ultimately, to find a cure.
Collaborations with Michigan Medicine researchers in Biomedical Engineering, Cardiovascular Medicine, and Vascular Surgery are taking on APS from all angles, using the latest advances in cell and molecular biology, pharmacology, genetics, and epigenetics.
Projects include:
- Pursuing anti-inflammatory treatments that might provide a more targeted approach with fewer side effects. Specifically, investigators are exploring the role that neutrophils, the most abundant white blood cells in the body, play in APS.
- The program collaborates with many national and international partners, providing our patients access to the latest clinical trials and study protocols.
Participate in APS Research
Patients who wish to are given the opportunity to participate in research at every clinic visit, by donating blood for studies into the genetic and cellular causes of APS.
These studies would not be possible without samples of blood from people who have antiphospholipid antibodies. By partnering with us in research, patients have a chance to make a positive impact on their own care and the care of future patients around the world.
- To learn more about our research, please visit our lab website.
- To learn more about current clinical studies, visit our antiphospholipid study page on UMHealthResearch.org
To receive updates on our patient care and research efforts, please join our APS Program email list.